Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2025
2024
2023
2022
2021
2020
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2025
Home
2025
March 3, 2025
Published by
Dominic Burg
on
March 3, 2025
Categories
Roquefort Therapeutics Announcement
March 3, 2025
Published by
Dominic Burg
on
March 3, 2025
Categories
AN1 – 1H25 Update
March 3, 2025
Published by
Dominic Burg
on
March 3, 2025
Categories
Notice of General Meeting/Proxy Form
March 3, 2025
Published by
Dominic Burg
on
March 3, 2025
Categories
Anagenics – 1H FY25 Half Year Report
March 3, 2025
Published by
Dominic Burg
on
March 3, 2025
Categories
AN1 – Appendix 4D 1H FY2025
March 3, 2025
Published by
Dominic Burg
on
March 3, 2025
Categories
Update on 2Q25 Activity Report
March 3, 2025
Published by
Dominic Burg
on
March 3, 2025
Categories
Roquefort Therapeutics Announcement
March 3, 2025
Published by
Dominic Burg
on
March 3, 2025
Categories
Q2 F25 Activity Statement and Appendix 4C
March 3, 2025
Published by
Dominic Burg
on
March 3, 2025
Categories
Long Term Suspended Entities
1
2
Next page
